Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Painkiller Linked to Overdose Deaths

By HospiMedica staff writers
Posted on 11 Dec 2001
Following a review of autopsy data, officials of the US Drug Enforcement Administration (DEA) have concluded that the painkiller OxyContin was a factor in the overdose deaths of 110 people over the last 19 months. More...
The study did not attempt to determine whether the drug alone was responsible for the deaths since the deaths involved multiple drugs.

Previously, overdose deaths by people taking OxyContin were believed to have been caused by people snorting or injecting crushed pills, a faster and more dangerous way to take the drug. However, the federal review showed that almost all of the overdose deaths were of people who had swallowed OxyContin whole or crushed into powder. Since the beginning of 2000, federal officials say around 500 people have died from overdoses involving oxycodone, the addictive narcotic in the drug and in other painkillers. However, they were unable to determine if all the overdoses were caused by OxyContin.

Recently, the manufacturer of OxyContin, Purdue Pharma L.P. (Stamford, CT) announced the beginning of clinical studies of a new drug containing oxycodone in a controlled-release formulation with an opiod antagonist, naloxone. The new version is designed to reduce intravenous abuse of OxyContin tablets. If the tablet is crushed and injected, the naloxone is released into the bloodstream, where it counteracts the effect of the oxycodone, diminishing the euphoria sought by the abuser. However, the recent findings that almost all the OxyContin-linked overdose deaths were of people who swallowed the drug would appear to indicate that this new version of OxyContin may not solve the abuse problem.




Related Links:
Purdue Pharma

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.